Anthony Traboulsee

Anthony Traboulsee

UNVERIFIED PROFILE

Are you Anthony Traboulsee?   Register this Author

Register author
Anthony Traboulsee

Anthony Traboulsee

Publications by authors named "Anthony Traboulsee"

Are you Anthony Traboulsee?   Register this Author

100Publications

2279Reads

7Profile Views

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Neurol Neuroimmunol Neuroinflamm 2019 Sep 28;6(5):e583. Epub 2019 Jun 28.

University of Utah School of Medicine (L.J.C., J.W.R., J.S.A., A.M.J., R.K., B.M., M.P., R.E., J.Y., S.M.), Salt Lake City; Division of Neuroimmunology and Multiple Sclerosis Center (M.H.H.), Department of Neurology and Neurological Sciences, Stanford University; Department of Neurology and Neurological Sciences (A.J.T.), Stanford School of Medicine, CA; Department of Neurology, Johns Hopkins University School of Medicine (M.L., M.A.M., J.C.), Baltimore, MD; Departments of Neurology and Ophthalmology (J.L.B., R.J., M.B.-G.), University of Colorado School of Medicine, Aurora; Department of Medicine & Neurology (A.L.T., R.L.C., L.E.L., J.J.S., K.M.), University of British Columbia, Vancouver, Canada; NYU Langone Health (I.K., Z.R., A.R.), New York; Department of Neurology, Cedars-Sinai Medical Center (N.L.S.), Los Angeles, CA; Mellen Center for MS Treatment and Research (S.M.P., J.A.C., D.I., J.L.S.), Neurological Institute, Cleveland Clinic, OH; Icahn School of Medicine at Mount Sinai (I.K.S.), New York; Multiple Sclerosis Center (P.R.), Swedish Neuroscience Institute, Seattle, WA; Department of Neurology (L.A., A.P., E.A.), Keck School of Medicine, University of Southern California, Los Angeles; Department of Neurology (T.C., D.S.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Neurology (E.C.K., A.W.R.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (C.S.R., K.B.O., L.L., K.E.N.), Columbia University Medical Center; Weill Cornell Medicine (M.M.N., C.E., M.K.-H., M.M.), New York; Department of Neurology (L.T.), Division of Multiple Sclerosis, University of Miami Miller School of Medicine, FL; PPD (A.R., A.G.), Wilmington, NC; The Guthy-Jackson Charitable Foundation (M.K.B., R.R.R., D.W. Behne., D.W. Blackway, B.C., J.S., J.M.B.), Beverly Hills; Departments of Medicine and of Molecular Pharmacology (T.F.B.), Stanford University School of Medicine, CA; Kellogg Eye Center (T.J.S.), University of Michigan Medical School, Ann Arbor; Department of Medicine, University of California, Los Angeles (M.R.Y.); and Harbor-UCLA Medical Center/LABioMed (M.R.Y.), Torrance, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624150PMC
September 2019

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Neurol Neuroimmunol Neuroinflamm 2019 Sep 28;6(5). Epub 2019 Jun 28.

From the University of Utah School of Medicine (L.J.C., J.W.R., J.S.A., A.M.J., R.K., B.M., M.P., R.E., J.Y., S.M.), Salt Lake City; Division of Neuroimmunology and Multiple Sclerosis Center (M.H.H.), Department of Neurology and Neurological Sciences, Stanford University; Department of Neurology and Neurological Sciences (A.J.T.), Stanford School of Medicine, CA; Department of Neurology, Johns Hopkins University School of Medicine (M.L., M.A.M., J.C.), Baltimore, MD; Departments of Neurology and Ophthalmology (J.L.B., R.J., M.B.-G.), University of Colorado School of Medicine, Aurora; Department of Medicine & Neurology (A.L.T., R.L.C., L.E.L., J.J.S., K.M.), University of British Columbia, Vancouver, Canada; NYU Langone Health (I.K., Z.R., A.R.), New York; Department of Neurology, Cedars-Sinai Medical Center (N.L.S.), Los Angeles, CA; Mellen Center for MS Treatment and Research (S.M.P., J.A.C., D.I., J.L.S.), Neurological Institute, Cleveland Clinic, OH; Icahn School of Medicine at Mount Sinai (I.K.S.), New York; Multiple Sclerosis Center (P.R.), Swedish Neuroscience Institute, Seattle, WA; Department of Neurology (L.A., A.P., E.A.), Keck School of Medicine, University of Southern California, Los Angeles; Department of Neurology (T.C., D.S.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Neurology (E.C.K., A.W.R.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (C.S.R., K.B.O., L.L., K.E.N.), Columbia University Medical Center; Weill Cornell Medicine (M.M.N., C.E., M.K.-H., M.M.), New York; Department of Neurology (L.T.), Division of Multiple Sclerosis, University of Miami Miller School of Medicine, FL; PPD (A.R., A.G.), Wilmington, NC; The Guthy-Jackson Charitable Foundation (M.K.B., R.R.R., D.W. Behne., D.W. Blackway, B.C., J.S., J.M.B.), Beverly Hills; Departments of Medicine and of Molecular Pharmacology (T.F.B.), Stanford University School of Medicine, CA; Kellogg Eye Center (T.J.S.), University of Michigan Medical School, Ann Arbor; Department of Medicine, University of California, Los Angeles (M.R.Y.); and Harbor-UCLA Medical Center/LABioMed (M.R.Y.), Torrance, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000583DOI Listing
September 2019

Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy?

J Magn Reson Imaging 2019 Jul 4;50(1):201-208. Epub 2018 Dec 4.

UBC MRI Research Centre, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.26561DOI Listing
July 2019

Laboratory Monitoring Practices Among Canadian Multiple Sclerosis Clinicians.

Can J Neurol Sci 2019 Jul 21;46(4):389-393. Epub 2019 May 21.

Undergraduate Medicine,University of British Columbia,Vancouver, British Columbia,Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2019.19DOI Listing
July 2019

Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.

BMC Neurol 2019 Jul 20;19(1):173. Epub 2019 Jul 20.

Division of Neurology, University of British Columbia, Djavad Mowafaghian Center for Brain Health, 2215 Wesbrook Mall, Vancouver, British Columbia, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-019-1382-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642472PMC
July 2019

Intra- and inter-site reproducibility of human brain single-voxel proton MRS at 3 T.

NMR Biomed 2019 06 19;32(6):e4083. Epub 2019 Mar 19.

Physics & Astronomy, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nbm.4083DOI Listing
June 2019

Rapid myelin water imaging for the assessment of cervical spinal cord myelin damage.

Neuroimage Clin 2019 17;23:101896. Epub 2019 Jun 17.

Physics and Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, BC V6T 1Z1, Canada; Radiology, University of British Columbia, 2775 Laurel Street, Vancouver, BC V5Z 1M9, Canada; International Collaboration on Repair Discoveries, University of British Columbia, 818 West 10th Avenue, Vancouver, BC V5Z 1M9, Canada; Medicine (Neurology), University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nicl.2019.101896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611998PMC
June 2019

A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab.

Mult Scler 2019 May 17;25(6):811-818. Epub 2018 Apr 17.

Division of Neurology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518770085DOI Listing
May 2019

Three-dimensional MRI sequences in MS diagnosis and research.

Mult Scler 2019 May 22:1352458519848100. Epub 2019 May 22.

Department of Radiology, The University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519848100DOI Listing
May 2019

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Neurology 2019 Mar 20;92(11):519-533. Epub 2019 Feb 20.

From the Division of Neurology (J.O.), St. Michael's Hospital, University of Toronto, Canada; Department of Neurology (J.O., P.A.C., B.D., D.S.R.), Johns Hopkins University, Baltimore, MD; Mellen Center for Multiple Sclerosis (D.O.), Cleveland Clinic, OH; Department of Neurology (C.A., D.P.), University of Southern California, Los Angeles; Department of Neurology (E.C.K.), Massachusetts General Hospital, Harvard Medical School, Boston; Translational Neuroradiology Unit (M.A., G.N., P.S., D.S.R.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; Brain Imaging Centre (D.L.A., S.N.), Montreal Neurological Institute, McGill University, Canada; Departments of Neurology (R.B.) and Radiology (R.B.), Brigham and Women's Hospital, Harvard Medical School, Boston; Department of Biostatistics (C.C.), Johns Hopkins School of Public Health, Baltimore, MD; Department of Neurology (L.F.), University of Texas Health Science Center at Houston; Department of Neurology (S.G., Y.W.), Weill Cornell Medical College, Cornell University, Ithaca, NY; Department of Neurology (R.H.), University of California at San Francisco; Department of Neurology (M.I., A.T.), Mount Sinai Hospital, New York, NY; Division of Neurology, Department of Medicine (S.K., D.K.B.L.), Department of Radiology (S.K., D.K.B.L., A.R.), Department of Physics and Astronomy (S.K., A.R., A.T., Y.Y.), MS/MRI Research Group (S.K., D.K.B.L., A.T., Y.Y.), MRI Research Centre (S.K., D.K.B.L., A.R.), and Department of Pediatrics (A.R.), University of British Columbia, Vancouver, Canada; A. A. Martinos Center for Biomedical Imaging (C.M.), Department of Radiology, Massachusetts General Hospital, Boston; Centre for Functional and Metabolic Mapping (R.S.M.), Robarts Research Institute, Western University, London, CA; Department of Neurology (F.N.), University of Minnesota, Minneapolis; Advanced Imaging Research Center (W.R., D.S., I.T.), Oregon Health & Science University, Portland; Department of Biostatistics, Epidemiology, and Informatics (R.T.S.), University of Pennsylvania Perelman School of Medicine, Philadelphia; Division of Neuroradiology and Neurophysics (T.Y.), University College London Institute of Neurology, UK; Department of Radiology (Y.Z.) and Department of Clinical Neurosciences and Hotchkiss Brain Institute (Y.Z.), University of Calgary, Canada; and Department of Neurology (N.L.S.), Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511106PMC
March 2019

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS.

Mult Scler J Exp Transl Clin 2019 Jan-Mar;5(1):2055217318823796. Epub 2019 Feb 16.

University of British Columbia, Department of Medicine (Neurology), Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217318823796DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378456PMC
February 2019

Longitudinal advanced MRI case report of white matter radiation necrosis.

Ann Clin Transl Neurol 2019 02 10;6(2):379-385. Epub 2018 Dec 10.

Department of Medicine Division of Neurology University of British Columbia Vancouver British Columbia Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.704DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389755PMC
February 2019

Multicenter Measurements of T Relaxation and Diffusion Tensor Imaging: Intra and Intersite Reproducibility.

J Neuroimaging 2019 Jan 19;29(1):42-51. Epub 2018 Sep 19.

Department of Radiology, University of British Columbia, UBC MRI Research Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jon.12559DOI Listing
January 2019

Diffusely Abnormal White Matter, T Burden of Disease, and Brain Volume in Relapsing-Remitting Multiple Sclerosis.

J Neuroimaging 2019 Jan 30;29(1):151-159. Epub 2018 Oct 30.

Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jon.12574
Publisher Site
http://dx.doi.org/10.1111/jon.12574DOI Listing
January 2019

Case of alemtuzumab-related alopecia areata management in MS.

Neurol Neuroimmunol Neuroinflamm 2019 01 19;6(1):e516. Epub 2018 Oct 19.

Department of Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://nn.neurology.org/lookup/doi/10.1212/NXI.0000000000000
Publisher Site
http://dx.doi.org/10.1212/NXI.0000000000000516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278852PMC
January 2019

Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?

Mult Scler J Exp Transl Clin 2019 Jan-Mar;5(1):2055217318824612. Epub 2019 Jan 16.

Department of Medicine (Neurology), University of British Columbia, CanadaThe first two and final two authors contributed equally to the manuscript.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217318824612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350151PMC
January 2019

Education, and the balance between dynamic and stationary functional connectivity jointly support executive functions in relapsing-remitting multiple sclerosis.

Hum Brain Mapp 2018 12 21;39(12):5039-5049. Epub 2018 Sep 21.

Graduate Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hbm.24343DOI Listing
December 2018

Goodpasture's Syndrome Following Alemtuzumab Therapy in Multiple Sclerosis.

Can J Neurol Sci 2018 11 2;45(6):712-714. Epub 2018 Oct 2.

5Department of Medicine,Division of Nephrology,University of British Columbia,Vancouver,British Columbia,Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2018.325DOI Listing
November 2018

Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter.

Mult Scler 2018 10 7;24(12):1557-1568. Epub 2017 Aug 7.

Department of Radiology, The University of British Columbia, Vancouver, BC, Canada/Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada/International Collaboration on Repair Discoveries (ICORD), The University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517723717DOI Listing
October 2018

Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial.

Neurology 2018 10 28;91(18):e1660-e1668. Epub 2018 Sep 28.

From the University of British Columbia, Departments of Medicine (Neurology) (A.L.T., S.I., J.I., A.D.S.), Radiology (L.M., D.K., D.K.L.), Medical Genetics (A.D.S.), and Statistics (J.N.B.), Vancouver; Centre Hospitalier de l'Université de Montréal (J.M.G., J.R.), Hôpital Notre-Dame, Montreal; Health Sciences Centre (R.V., B.W.H.), Winnipeg; Centre Hospitalier Universitaire de Québec-Université Laval (F.E., J.-L.G.), Hôpital Enfant-Jésus, Quebec, Canada; and Albany Medical Center (G.S.), NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006423DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207414PMC
October 2018

Nothing Ventured, Nothing Gained? Navigating Disease-Modifying Treatment in Multiple Sclerosis.

Can J Neurol Sci 2018 09;45(5):487-488

2Department of Medicine,Division of NeurologyUniversity of British Columbia,Vancouver,Canada.

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S031716711
Publisher Site
http://dx.doi.org/10.1017/cjn.2018.317DOI Listing
September 2018

Reflections on translation: Views of participants in a multisite Canadian CCSVI clinical trial.

Neurol Clin Pract 2018 Jun;8(3):232-239

Neuroethics Canada (SB, CL, JI) and Division of Neurology, Department of Medicine (SB, CL, JI, AT), University of British Columbia, Vancouver, Canada. SB is currently affiliated with AbilityLab, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075987PMC
June 2018

Resilience, trust, and civic engagement in the post-CCSVI era.

BMC Health Serv Res 2018 05 16;18(1):366. Epub 2018 May 16.

Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Illinois, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12913-018-3130-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956844PMC
May 2018

Analysis of NOD-like receptor NLRP1 in multiple sclerosis families.

Immunogenetics 2018 03 7;70(3):205-207. Epub 2017 Oct 7.

Department of Medical Genetics, University of British Columbia, 5639-2215 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00251-017-1034-2DOI Listing
March 2018

Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation.

Mult Scler Relat Disord 2018 Feb 23;20:37-42. Epub 2017 Dec 23.

Department of Medicine, Division of Neurology, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2017.12.012DOI Listing
February 2018

Rapid myelin water imaging in human cervical spinal cord.

Magn Reson Med 2017 10 9;78(4):1482-1487. Epub 2016 Nov 9.

Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mrm.26551DOI Listing
October 2017

Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy.

Neurology 2017 Sep 23;89(11):1107-1116. Epub 2017 Aug 23.

From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595278PMC
September 2017

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.

Neurology 2017 Sep 23;89(11):1117-1126. Epub 2017 Aug 23.

From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595276PMC
September 2017

Cognitive Performance in Subjects With Multiple Sclerosis Is Robustly Influenced by Gender in Canonical-Correlation Analysis.

J Neuropsychiatry Clin Neurosci 2017 30;29(2):119-127. Epub 2016 Nov 30.

From the Graduate Program in Neuroscience, University of British Columbia (S-JL, MM); the Department of Statistics, University of British Columbia (JL); the Graduate Program in Counselling Psychology, University of British Columbia (SB); the Department of Radiology, University of British Columbia (IV, AM); the Department of Neurology, Faculty of Medicine, University of British Columbia (AT, DL, MM); the Department of Physics and Astronomy, University of British Columbia (AM); and the Department of Psychiatry, University of British Columbia Hospital (BK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.neuropsych.16040083DOI Listing
August 2017

Susceptibility-sensitive MRI of multiple sclerosis lesions and the impact of normal-appearing white matter changes.

NMR Biomed 2017 Aug 4;30(8). Epub 2017 May 4.

Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nbm.3727DOI Listing
August 2017

Genetic modifiers of multiple sclerosis progression, severity and onset.

Clin Immunol 2017 07 10;180:100-105. Epub 2017 May 10.

Department of Medical Genetics, University of British Columbia, Vancouver, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2017.05.009DOI Listing
July 2017

Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review.

Autoimmun Rev 2017 Jun 17;16(6):658-665. Epub 2017 Apr 17.

Department of Medicine, University of Melbourne, 300 Grattan St, Melbourne 3050, Australia; Department of Neurology, Royal Melbourne Hospital, 300 Grattan St, Melbourne 3050, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2017.04.010DOI Listing
June 2017

Evaluating the safety of β-interferons in MS: A series of nested case-control studies.

Neurology 2017 Jun 12;88(24):2310-2320. Epub 2017 May 12.

From the Division of Neurology and Centre for Brain Health (H.J.I.d.J., E.K., A.S., Y.Z., F.Z., M.L.v.d.K., A.T., H.T.), Department of Medicine, and Vancouver Coastal Health Research Institute, University of British Columbia, Canada; School for Mental Health and Neuroscience (H.J.I.d.J., J.W.C.T., R.H.), Maastricht University Medical Center, the Netherlands; College of Pharmacy and Nutrition (C.E.), University of Saskatchewan, Saskatoon, Canada; Department Public Health Sciences (M.L.v.d.K.), Karolinska Institutet, Stockholm, Sweden; Department of Statistics (P.G., J.P.), University of British Columbia, Vancouver, Canada; and Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567323PMC
June 2017

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis.

N Engl J Med 2017 06;376(22):2122-2133

From the Cumming School of Medicine and the Hotchkiss Brain Institute, Calgary, AB (L.M.M., G.C., J.G., M.Y., M.D.H., V.W.Y.), the University of British Columbia, Vancouver (D.K.B.L., A.L.T., A.R.), the University of Montreal, Montreal (P.D.), Western University, London, ON (M.K.), Fraser Health MS Clinic, Burnaby, BC (G.V.), the University of Ottawa and the Ottawa Hospital Research Institute, Ottawa (M.S.F.), Dalhousie University, Halifax, NS (V.B.), the University of Alberta, Edmonton (G.B.), the University of Manitoba, Winnipeg (J.J.M.), Clinique Neuro Rive-Sud, Greenfield Park, QC (F.G.), the University of Toronto, Toronto (L.L.), and CHA-Hôpital Enfant-Jésus, Quebec, QC (M.T.) - all in Canada; and Tufts University, Boston (M.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1608889DOI Listing
June 2017

Patient-Reported Benefits of Extracranial Venous Therapy: British Columbia CCSVI Registry.

Can J Neurol Sci 2017 May 8;44(3):246-254. Epub 2017 Mar 8.

4Department of Medicine (Neurology),University of British Columbia,Vancouver,British Columbia,Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2017.27DOI Listing
May 2017

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

N Engl J Med 2017 01 21;376(3):221-234. Epub 2016 Dec 21.

From the University of California, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., P.C., H.G.) - both in California; McGill University (A.B.-O., D.L.A.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver, BC (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and the Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); Hospital Vall d'Hebron University, Barcelona (X.M.); University of Miami, Miami (K.W.R.); Medical University of Lodz and Center for Neurology, Lodz, Poland (K.S.); McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.); and F. Hoffmann-La Roche (G.K., P.F., S.B., N.M.) and University Hospital Basel, University of Basel (L.K.), Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1601277DOI Listing
January 2017

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

N Engl J Med 2017 01 21;376(3):209-220. Epub 2016 Dec 21.

From Hospital Vall d'Hebron University, Barcelona (X.M.); University of California, San Francisco, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., H.G., P.C.) - both in California; University Hospital Basel, University of Basel (L.K.), and F. Hoffmann-La Roche (A.S., P.F., S.B., N.M.), Basel, Switzerland; McGill University (D.L.A., A.B.-O.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); University Hospital of Strasbourg, Clinical Investigation Center (INSERM Unité 1434), Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France (J.S.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); University of Miami, Miami (K.W.R.); Medical University of Łódź, Łódź, Poland (K.S.); and McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1606468DOI Listing
January 2017

Longitudinal Study of Retinal Nerve Fiber Layer Thickness and Macular Volume in Patients With Neuromyelitis Optica Spectrum Disorder.

J Neuroophthalmol 2016 12;36(4):363-368

Department of Medicine (PM, ALT), University of British Columbia, Vancouver, Canada; Department of Ophthalmology (APL), University of British Columbia, Vancouver, Canada; and Vista Klinik (APL), Binningen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNO.0000000000000404DOI Listing
December 2016

Case-Control Studies Are Not Familial Studies.

Neuron 2016 Oct;92(2):339-341

Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuron.2016.09.053DOI Listing
October 2016

Brain health: time matters in multiple sclerosis.

Mult Scler Relat Disord 2016 Sep 7;9 Suppl 1:S5-S48. Epub 2016 Jul 7.

Department of Neurology, University of Colorado Denver, Aurora, CO, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.07.003DOI Listing
September 2016

Does hydration status affect MRI measures of brain volume or water content?

J Magn Reson Imaging 2016 08 29;44(2):296-304. Epub 2016 Jan 29.

Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.25168DOI Listing
August 2016

Orientation Dependent MR Signal Decay Differentiates between People with MS, Their Asymptomatic Siblings and Unrelated Healthy Controls.

PLoS One 2015 21;10(10):e0140956. Epub 2015 Oct 21.

UBC MRI Research Centre, University of British Columbia, Vancouver, Canada; Department of Pediatrics, University of British Columbia, Vancouver, Canada; Centre for Brain Health, University of British Columbia, Vancouver, Canada; Child and Family Research Institute, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140956PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619399PMC
July 2016

Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study.

Ther Adv Neurol Disord 2016 Jul 15;9(4):287-96. Epub 2016 May 15.

Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756285616648060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916526PMC
July 2016

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.

PLoS One 2015 18;10(9):e0137715. Epub 2015 Sep 18.

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom; Neurology Department, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0137715PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575169PMC
May 2016

Analysis of CH25H in multiple sclerosis and neuromyelitis optica.

J Neuroimmunol 2016 Feb 31;291:70-2. Epub 2015 Dec 31.

Department of Medical Genetics, University of British Columbia, Vancouver, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2015.12.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5092160PMC
February 2016

Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.

Can J Neurol Sci 2015 Jul 15;42(4):235-41. Epub 2015 Jun 15.

1Department of Medical Genetics,University of British Columbia,Vancouver,Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2015.36DOI Listing
July 2015

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Neurology 2015 Jul 19;85(2):177-89. Epub 2015 Jun 19.

From the Departments of Neurology (D.M.W.) and Library Services (K.E.W.), Mayo Clinic, Scottsdale, AZ; the Children's Hospital of Philadelphia (B.B.), PA; the Departments of Neurology and Ophthalmology (J.L.B.), University of Colorado Denver, Aurora; the Service de Neurologie (P.C.), Centre Hospitalier Universitaire de Fort de France, Fort-de-France, Martinique; Department of Neurology (W.C.), Sir Charles Gairdner Hospital, Perth, Australia; the Department of Neurology (T.C.), Massachusetts General Hospital, Boston; the Department of Neurology (J.d.S.), Strasbourg University, France; the Department of Multiple Sclerosis Therapeutics (K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan; the Departments of Neurology and Neurotherapeutics (B.G.), University of Texas Southwestern Medical Center, Dallas; The Walton Centre NHS Trust (A.J.), Liverpool, UK; the Molecular Neuroimmunology Group, Department of Neurology (S.J.), University Hospital Heidelberg, Germany; the Center for Multiple Sclerosis Investigation (M.L.-P.), Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil; the Department of Neurology (M.L.), Johns Hopkins University, Baltimore, MD; Portland VA Medical Center and Oregon Health and Sciences University (J.H.S.), Portland; the Department of Neurology (S.T.), National Pediatric Hospital Dr. Juan P. Garrahan, Buenos Aires, Argentina; the Department of Medicine (A.L.T.), University of British Columbia, Vancouver, Canada; Nuffield Department of Clinical Neurosciences (P.W.), University of Oxford, UK; and the Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001729DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515040PMC
July 2015

Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials.

Mult Scler J Exp Transl Clin 2015 Jan-Dec;1:2055217315577829. Epub 2015 Apr 24.

Department of Statistics, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217315577829DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433340PMC
April 2015

Fast computation of myelin maps from MRI T₂ relaxation data using multicore CPU and graphics card parallelization.

J Magn Reson Imaging 2015 Mar 27;41(3):700-7. Epub 2014 Feb 27.

Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada; Division of Neurology, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.24604DOI Listing
March 2015

An assessment of genetic counseling services for individuals with multiple sclerosis.

J Genet Couns 2015 Feb 5;24(1):46-57. Epub 2014 Jul 5.

Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-014-9735-2DOI Listing
February 2015

Health-related quality of life in patients with longstanding 'benign multiple sclerosis'.

Mult Scler Relat Disord 2015 Jan 7;4(1):31-8. Epub 2014 Oct 7.

Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, Canada; Brain Research Centre, Faculty of Medicine, University of British Columbia, Vancouver, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2014.09.211DOI Listing
January 2015

How useful are MS registries?

Mult Scler 2014 Oct;20(11):1423-4

University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514540844DOI Listing
October 2014

Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.

Neurogenetics 2014 Aug 26;15(3):165-9. Epub 2014 Apr 26.

Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10048-014-0403-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094890PMC
August 2014

Progressive multiple sclerosis does not associate with rs996343 and rs2046748.

Mult Scler 2014 May 24;20(6):766-7. Epub 2013 Dec 24.

Department of Medical Genetics, University of British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513517280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094894PMC
May 2014

Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs.

CNS Drugs 2014 May;28(5):475-82

Brain Research Centre and Department of Medicine (Division of Neurology), Faculty of Medicine, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-014-0154-6DOI Listing
May 2014

Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.

Lancet 2014 Jan 9;383(9912):138-45. Epub 2013 Oct 9.

Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)61747-XDOI Listing
January 2014

Analysis of CYP27B1 in multiple sclerosis.

J Neuroimmunol 2014 Jan 23;266(1-2):64-6. Epub 2013 Nov 23.

Department of Medical Genetics, University of British Columbia, Vancouver, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2013.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5092161PMC
January 2014

Obstetrical epidural and spinal anesthesia in multiple sclerosis.

J Neurol 2013 Oct 18;260(10):2620-8. Epub 2013 Jul 18.

Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia, Room S178, 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-013-7035-7DOI Listing
October 2013

Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients.

J Neuroophthalmol 2013 Sep;33(3):213-9

Neuro-Ophthalmology, Department of Ophthalmology (APL), University of British Columbia, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNO.0b013e31829c510eDOI Listing
September 2013

Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.

Ann Neurol 2013 Jul 12;74(1):91-9. Epub 2013 Aug 12.

Department of Radiology, University of Calgary, Calgary, Alberta; Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.23867DOI Listing
July 2013